These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 6406138

  • 1. Levonorgestrel plasma levels during continuous administration with different models of subdermal implants.
    Alvarez F, Brache V, Faundes A, Johansson ED, Odlind V, Nash H.
    Contraception; 1983 Feb; 27(2):123-30. PubMed ID: 6406138
    [Abstract] [Full Text] [Related]

  • 2. Plasma levels of levonorgestrel and free levonorgestrel index in women using NORPLANT implants or two covered rods (NORPLANT-2).
    Olsson SE, Odlind V, Johansson ED, Nordström ML.
    Contraception; 1987 Mar; 35(3):215-28. PubMed ID: 3111784
    [Abstract] [Full Text] [Related]

  • 3. Norplant contraceptive implants: rods versus capsules.
    Pasquale SA, Brandeis V, Cruz RI, Kelly S, Sweeney M.
    Contraception; 1987 Sep; 36(3):305-16. PubMed ID: 3119287
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. First year clinical experience with six levonorgestrel rods as subdermal contraception.
    Faundes A, Brache de Mejias V, Leon P, Robertson D, Alvarez F.
    Contraception; 1979 Aug; 20(2):167-75. PubMed ID: 487818
    [Abstract] [Full Text] [Related]

  • 6. A new delivery system for contraceptive steroids.
    Segal S.
    Am J Obstet Gynecol; 1987 Oct; 157(4 Pt 2):1090-2. PubMed ID: 3118719
    [Abstract] [Full Text] [Related]

  • 7. Long-term reversible contraception with levonorgestrel-releasing Silastic rods.
    Roy S, Mishell DR, Robertson DN, Krauss RM, Lacarra M, Duda MJ.
    Am J Obstet Gynecol; 1984 Apr 01; 148(7):1006-13. PubMed ID: 6424474
    [Abstract] [Full Text] [Related]

  • 8. Cholesterol and HDL-cholesterol values in women during use of subdermal implants releasing levonorgestrel.
    Holma P, Robertson DN.
    Contraception; 1985 Aug 01; 32(2):163-71. PubMed ID: 3935372
    [Abstract] [Full Text] [Related]

  • 9. Subdermal progestin implant contraception.
    Darney PD.
    Curr Opin Obstet Gynecol; 1991 Aug 01; 3(4):470-6. PubMed ID: 1908716
    [Abstract] [Full Text] [Related]

  • 10. Plasma levels of levonorgestrel in women during longterm use of Norplants.
    Croxatto HB, Díaz S, Miranda P, Elamsson K, Johansson ED.
    Contraception; 1980 Dec 01; 22(6):583-96. PubMed ID: 6971208
    [Abstract] [Full Text] [Related]

  • 11. Subdermal contraceptive implants.
    Peralta O, Diaz S, Croxatto H.
    J Steroid Biochem Mol Biol; 1995 Jun 01; 53(1-6):223-6. PubMed ID: 7626459
    [Abstract] [Full Text] [Related]

  • 12. Contraception with subdermal implants releasing levonorgestrel. A clinical and pharmacological study.
    Olsson SE.
    Acta Obstet Gynecol Scand Suppl; 1987 Jun 01; 142():1-45. PubMed ID: 3116821
    [Abstract] [Full Text] [Related]

  • 13. Androgen levels in women using Norplant implants.
    Olsson SE, Odlind V, Johansson E.
    Contraception; 1986 Aug 01; 34(2):157-67. PubMed ID: 2946553
    [Abstract] [Full Text] [Related]

  • 14. Ovarian endocrine function through five years of continuous treatment with NORPLANT subdermal contraceptive implants.
    Brache V, Alvarez-Sanchez F, Faundes A, Tejada AS, Cochon L.
    Contraception; 1990 Feb 01; 41(2):169-77. PubMed ID: 2107058
    [Abstract] [Full Text] [Related]

  • 15. Ultrasonic visualization of NORPLANT subdermal contraceptive devices.
    Thomsen RJ, Pasquale S, Nosher J.
    Int J Gynaecol Obstet; 1985 Jun 01; 23(3):223-7. PubMed ID: 2865186
    [Abstract] [Full Text] [Related]

  • 16. Release rates of levonorgestrel from Silastic capsules, homogeneous rods and covered rods in humans.
    Robertson DN, Sivin I, Nash HA, Braun J, Dinh J.
    Contraception; 1983 May 01; 27(5):483-95. PubMed ID: 6411428
    [Abstract] [Full Text] [Related]

  • 17. Immediate postabortal contraception with Norplant: levonorgestrel, gonadotropin, estradiol, and progesterone levels over two postabortal months and return of fertility after removal of Norplant capsules.
    Kurunmäki H, Toivonen J, Lähteenmäki PL, Luukkainen T.
    Contraception; 1984 Nov 01; 30(5):431-42. PubMed ID: 6440739
    [Abstract] [Full Text] [Related]

  • 18. Plasma progesterone levels during long-term treatment with levonorgestrel silastic implants.
    Croxatto HB, Diaz S, Pavez M, Miranda P, Brandeis A.
    Acta Endocrinol (Copenh); 1982 Oct 01; 101(2):307-11. PubMed ID: 6814139
    [Abstract] [Full Text] [Related]

  • 19. Effect of levonorgestrel contraceptive implants, Norplant, on blood coagulation.
    Shaaban MM, Elwan SI, el-Kabsh MY, Farghaly SA, Thabet N.
    Contraception; 1984 Nov 01; 30(5):421-30. PubMed ID: 6440738
    [Abstract] [Full Text] [Related]

  • 20. Contraception by Norplant subdermal capsules is not reliable in epileptic patients on anticonvulsant treatment.
    Haukkamaa M.
    Contraception; 1986 Jun 01; 33(6):559-65. PubMed ID: 3095023
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.